State Key Laboratory of Military Stomatology & National Clinical Research Center for Oral Diseases & Shaanxi Key Laboratory of Oral Diseases, Department of Periodontology, School of Stomatology, Fourth Military Medical University, 145 West Changle Road, Xi'an 710032, China; Department of Biomedical Sciences, Texas A&M University College of Dentistry, 3302 Gaston Ave, Dallas, TX 75246, United States.
State Key Laboratory of Military Stomatology & National Clinical Research Center for Oral Diseases & Shaanxi Key Laboratory of Oral Diseases, Department of Periodontology, School of Stomatology, Fourth Military Medical University, 145 West Changle Road, Xi'an 710032, China.
Mater Sci Eng C Mater Biol Appl. 2019 Aug;101:330-340. doi: 10.1016/j.msec.2019.03.107. Epub 2019 Mar 29.
Extracellular matrices (ECMs) derived from native tissues/organs have been used as biomaterials for tissue engineering and regenerative medicine in a wide range of preclinical and clinical settings. The success or failure of these applications is largely contingent on the host responses to the matrices in vivo. Despite retaining their native structural and functional proteins, bone ECM-based transplants have been reported to evoke adverse immune responses in many cases; thus, optimizing the immunomodulatory properties of bone ECMs is critical for ensuring downstream regenerative outcomes. Using a simple digestion-neutralization protocol, we transformed the commonly used bone-derived filler particles into gel bioscaffolds. Instead of inducing macrophages toward proinflammatory (M1) polarization, as reported in the literature and confirmed in the present study for ECM particles, the ECM gels were found to be more likely to polarize macrophages toward regulatory/anti-inflammatory (M2) phenotypes, leading to enhanced tissue regeneration in a rat periodontal defect model. The present work demonstrates a simple, practical and economical strategy to modify the immunomodulatory properties of bone ECMs before their in vivo transplantation and hence has important implications that may facilitate the use of ECM-based bioscaffolds derived from diverse sources of tissues for regenerative purposes.
从天然组织/器官中提取的细胞外基质 (ECM) 已被广泛应用于临床前和临床环境中的组织工程和再生医学作为生物材料。这些应用的成功或失败在很大程度上取决于宿主对体内基质的反应。尽管保留了其天然的结构和功能蛋白,但据报道,基于骨 ECM 的移植物在许多情况下会引起不良的免疫反应;因此,优化骨 ECM 的免疫调节特性对于确保下游再生结果至关重要。我们使用简单的消化中和方案,将常用的骨衍生填充颗粒转化为凝胶生物支架。与文献中报道的和本研究中证实的 ECM 颗粒相反,ECM 凝胶不会诱导巨噬细胞向促炎(M1)极化,而是更有可能将巨噬细胞向调节/抗炎(M2)表型极化,从而在大鼠牙周缺损模型中增强组织再生。本工作展示了一种简单、实用和经济的策略,可在骨 ECM 体内移植前改变其免疫调节特性,因此具有重要意义,可能促进基于 ECM 的生物支架在再生目的上的广泛应用。